0913693 B.C. Ltd. (REPCF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Sep 14, 2026
0913693 B.C. Market Cap
0913693 B.C. has a market cap or net worth of $7.36 thousand as of September 18, 2026.
Market Cap
7.36K
Enterprise Value
795.09K
Revenue
249.09K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since December 23, 2010, 0913693 B.C.'s market cap has decreased from 15.90M to 7.36K, a decrease of -99.95%. That is a compound annual growth rate of -38.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 7.36K | -90.00% |
| Dec 24, 2024 | 73.58K | -97.48% |
| Dec 29, 2023 | 2.93M | 33.12% |
| Dec 30, 2022 | 2.20M | -68.55% |
| Dec 31, 2021 | 6.99M | 22.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneLink | 10.60K |
| Navidea Biopharmaceuticals | 10.00K |
| Bioasis Technologies | 7.94K |
| IO Biotech | 7.20K |
| Therapeutic Solutions International | 7.05K |
| Theralink Technologies | 6.15K |
| Hard to Treat Diseases | 5.82K |
| FluoroPharma Medical | 5.52K |